Crosstalk between adipokines and myokines in fat browning

Acta Physiologica

Volumn 219, Issue 2, 2017, Pages 362-381

  Rodriguez A ^a,b,c   Becerril, S ^a,b,c   Ezquerro, S ^a   Mendez Gimenez L ^a,b,c   Fruhbeck G ^a,b,c  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c IdiSNA Navarra Institute for Health Research   (Spain)

Author keywords

adipokines; beige adipocytes; energy expenditure; myokines

Indexed keywords

3 AMINO 2 METHYLPROPIONIC ACID; ADIPOCYTOKINE; CYTOKINE; FIBROBLAST GROWTH FACTOR 21; FOLLISTATIN LIKE 1; INTERLEUKIN 15; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; IRISIN; LEPTIN; LEUKEMIA INHIBITORY FACTOR; METEORIN LIKE PROTEIN; MYOKINE; MYONECTIN; MYOSTATIN; UNCLASSIFIED DRUG; FIBRONECTIN;

ADIPOGENESIS; AUTOCRINE EFFECT; BEIGE ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; CYTOKINE RELEASE; ENDOCRINE GLAND; ENERGY EXPENDITURE; EXERCISE; GLYCATION; HUMAN; INTRAPERITONEAL FAT; METABOLIC REGULATION; MUSCLE DEVELOPMENT; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CROSS LINKING; PROTEIN PROTEIN INTERACTION; REVIEW; SKELETAL MUSCLE; SUBCUTANEOUS FAT; TRANSCRIPTION REGULATION; WHITE ADIPOCYTE; ANIMAL; METABOLISM; SIGNAL TRANSDUCTION;

ADIPOKINES; ADIPOSE TISSUE, BROWN; ANIMALS; FIBRONECTINS; HUMANS; RECEPTOR CROSS-TALK;

EID: 85010850003     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12686     Document Type: Review

References (192)

1. Adams, A.C., Yang, C., Coskun, T., Cheng, C.C., Gimeno, R.E., Luo, Y. & Kharitonenkov, A. 2012. The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. Mol Metab 2, 31–37.
2. Albrecht, E., Norheim, F., Thiede, B., Holen, T., Ohashi, T., Schering, L., Lee, S., Brenmoehl, J., Thomas, S., Drevon, C.A., Erickson, H.P. & Maak, S. 2015. Irisin – a myth rather than an exercise-inducible myokine. Sci Rep 5, 8889.
3. Amir Levy, Y., Ciaraldi, T.P., Mudaliar, S.R., Phillips, S.A. & Henry, R.R. 2015. Excessive secretion of IL-8 by skeletal muscle in type 2 diabetes impairs tube growth: potential role of PI3K and the Tie2 receptor. Am J Physiol Endocrinol Metab 309, E22–E34.
4. Amthor, H., Nicholas, G., McKinnell, I., Kemp, C.F., Sharma, M., Kambadur, R. & Patel, K. 2004. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 270, 19–30.
5. Arounleut, P., Bowser, M., Upadhyay, S., Shi, X.M., Fulzele, S., Johnson, M.H., Stranahan, A.M., Hill, W.D., Isales, C.M. & Hamrick, M.W. 2013. Absence of functional leptin receptor isoforms in the POUND (Lepr(db/lb)) mouse is associated with muscle atrophy and altered myoblast proliferation and differentiation. PLoS ONE 8, e72330.
6. Badman, M.K., Pissios, P., Kennedy, A.R., Koukos, G., Flier, J.S. & Maratos-Flier, E. 2007. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5, 426–437.
7. Bartelt, A. & Heeren, J. 2014. Adipose tissue browning and metabolic health. Nat Rev Endocrinol 10, 24–36.
8. Bartoccioni, E., Michaelis, D. & Hohlfeld, R. 1994. Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol Lett 42, 135–138.
9. Becerril, S., Rodríguez, A., Catalán, V., Sáinz, N., Ramírez, B., Collantes, M., Peñuelas, I., Gómez-Ambrosi, J. & Frühbeck, G. 2010. Deletion of inducible nitric-oxide synthase in leptin-deficient mice improves brown adipose tissue function. PLoS ONE 5, e10962.
10. Becerril, S., Rodríguez, A., Catalán, V., Sáinz, N., Ramírez, B., Gómez-Ambrosi, J. & Frühbeck, G. 2012. Transcriptional analysis of brown adipose tissue in leptin-deficient mice lacking inducible nitric oxide synthase: evidence of the role of Med1 in energy balance. Physiol Genomics 44, 678–688.
11. Becerril, S., Gómez-Ambrosi, J., Martín, M., Moncada, R., Sesma, P., Burrell, M.A. & Frühbeck, G. 2013. Role of PRDM16 in the activation of brown fat programming. Relevance to the development of obesity. Histol Histopathol 28, 1411–1425.
12. Begriche, K., Massart, J., Abbey-Toby, A., Igoudjil, A., Letteron, P. & Fromenty, B. 2008. Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency. Obesity 16, 2053–2067.
13. Besse-Patin, A., Montastier, E., Vinel, C., Castan-Laurell, I., Louche, K., Dray, C., Daviaud, D., Mir, L., Marques, M.A., Thalamas, C., Valet, P., Langin, D., Moro, C. & Viguerie, N. 2014. Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine. Int J Obes 38, 707–713.
14. Blair, S.N., Kohl, H.W. 3rd, Barlow, C.E., Paffenbarger, R.S. Jr, Gibbons, L.W. & Macera, C.A. 1995. Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA 273, 1093–1098.
15. Bonet, M.L., Oliver, P. & Palou, A. 2013. Pharmacological and nutritional agents promoting browning of white adipose tissue. Biochim Biophys Acta 1831, 969–985.
16. Bordicchia, M., Liu, D., Amri, E.Z., Ailhaud, G., Dessi-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R. & Collins, S. 2012. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 122, 1022–1036.
17. Boström, P.A. & Fernández-Real, J.M. 2014. Metabolism: Irisin, the metabolic syndrome and follistatin in humans. Nat Rev Endocrinol 10, 11–12.
18. Boström, P., Wu, J., Jedrychowski, M.P., Korde, A., Ye, L., Lo, J.C., Rasbach, K.A., Böstrom, E.A., Choi, J.H., Long, J.Z. et al. 2012. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463–468.
19. Boström, P.A., Fernández-Real, J.M. & Mantzoros, C. 2014. Irisin in humans: recent advances and questions for future research. Metabolism 63, 178–180.
20. Braga, M., Reddy, S.T., Vergnes, L., Pervin, S., Grijalva, V., Stout, D., David, J., Li, X., Tomasian, V., Reid, C.B., Norris, K.C., Devaskar, S.U., Reue, K. & Singh, R. 2014. Follistatin promotes adipocyte differentiation, browning, and energy metabolism. J Lipid Res 55, 375–384.
21. Broholm, C., Mortensen, O.H., Nielsen, S., Akerstrom, T., Zankari, A., Dahl, B. & Pedersen, B.K. 2008. Exercise induces expression of leukaemia inhibitory factor in human skeletal muscle. J Physiol 586, 2195–2201.
22. Broholm, C., Laye, M.J., Brandt, C., Vadalasetty, R., Pilegaard, H., Pedersen, B.K. & Scheele, C. 2011. LIF is a contraction-induced myokine stimulating human myocyte proliferation. J Appl Physiol (1985), 111, 251–259.
23. Cannon, B. & Nedergaard, J. 2004. Brown adipose tissue: function and physiological significance. Physiol Rev 84, 277–359.
24. Carbo, N., Lopez-Soriano, J., Costelli, P., Alvarez, B., Busquets, S., Baccino, F.M., Quinn, L.S., Lopez-Soriano, F.J. & Argiles, J.M. 2001. Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim Biophys Acta 1526, 17–24.
25. Carrière, A., Jeanson, Y., Berger-Müller, S., André, M., Chenouard, V., Arnaud, E., Barreau, C., Walther, R., Galinier, A., Wdziekonski, B. et al. 2014. Browning of white adipose cells by intermediate metabolites: an adaptive mechanism to alleviate redox pressure. Diabetes 63, 3253–3265.
26. Catoire, M., Alex, S., Paraskevopulos, N., Mattijssen, F., Evers-van Gogh, I., Schaart, G., Jeppesen, J., Kneppers, A., Mensink, M., Voshol, P.J. et al. 2014a. Fatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise. Proc Natl Acad Sci USA 111, E1043–E1052.
27. Catoire, M., Mensink, M., Kalkhoven, E., Schrauwen, P. & Kersten, S. 2014b. Identification of human exercise-induced myokines using secretome analysis. Physiol Genomics 46, 256–267.
28. Chartoumpekis, D.V., Habeos, I.G., Ziros, P.G., Psyrogiannis, A.I., Kyriazopoulou, V.E. & Papavassiliou, A.G. 2011. Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Mol Med 17, 736–740.
29. Chavez, A.O., Molina-Carrion, M., Abdul-Ghani, M.A., Folli, F., Defronzo, R.A. & Tripathy, D. 2009. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance. Diabetes Care 32, 1542–1546.
30. Chen, Y., Siegel, F., Kipschull, S., Haas, B., Frohlich, H., Meister, G. & Pfeifer, A. 2013. miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit. Nat Commun 4, 1769.
31. Choi, H.Y., Kim, S., Park, J.W., Lee, N.S., Hwang, S.Y., Huh, J.Y., Hong, H.C., Yoo, H.J., Baik, S.H., Youn, B.S., Mantzoros, C.S. & Choi, K.M. 2014. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. J Clin Endocrinol Metab 99, 2778–2785.
32. Cinti, S. 2012. The adipose organ at a glance. Dis Model Mech 5, 588–594.
33. Dempersmier, J., Sambeat, A., Gulyaeva, O., Paul, S.M., Hudak, C.S., Raposo, H.F., Kwan, H.Y., Kang, C., Wong, R.H. & Sul, H.S. 2015. Cold-inducible Zfp516 activates UCP1 transcription to promote browning of white fat and development of brown fat. Mol Cell 57, 235–246.
34. Dinas, P.C., Nikaki, A., Jamurtas, A.Z., Prassopoulos, V., Efthymiadou, R., Koutedakis, Y., Georgoulias, P. & Flouris, A.D. 2015. Association between habitual physical activity and brown adipose tissue activity in individuals undergoing PET-CT scan. Clin Endocrinol 82, 147–154.
35. Douris, N., Stevanovic, D.M., Fisher, F.M., Cisu, T.I., Chee, M.J., Nguyen, N.L., Zarebidaki, E., Adams, A.C., Kharitonenkov, A., Flier, J.S., Bartness, T.J. & Maratos-Flier, E. 2015. Central fibroblast growth factor 21 browns white fat via sympathetic action in male mice. Endocrinology 156, 2470–2481.
36. Enerbäck, S. 2009. The origins of brown adipose tissue. N Engl J Med 360, 2021–2023.
37. Erickson, H.P. 2013. Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor? Adipocyte 2, 289–293.
38. Febbraio, M.A., Hiscock, N., Sacchetti, M., Fischer, C.P. & Pedersen, B.K. 2004. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53, 1643–1648.
39. Feldman, B.J., Streeper, R.S., Farese, R.V. Jr & Yamamoto, K.R. 2006. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci USA 103, 15675–15680.
40. Fisher, F.M., Kleiner, S., Douris, N., Fox, E.C., Mepani, R.J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J.S., Maratos-Flier, E. & Spiegelman, B.M. 2012. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 26, 271–281.
41. Friedman, J.M. & Mantzoros, C.S. 2015. 20 years of leptin: from the discovery of the leptin gene to leptin in our therapeutic armamentarium. Metabolism 64, 1–4.
42. Frühbeck, G. 2008. Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol Biol 456, 1–22.
43. Frühbeck, G., Aguado, M. & Martínez, J.A. 1997. In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun 240, 590–594.
44. Frühbeck, G., Aguado, M., Gómez-Ambrosi, J. & Martínez, J.A. 1998. Lipolytic effect of in vivo leptin administration on adipocytes of lean and ob/ob mice, but not db/db mice. Biochem Biophys Res Commun 250, 99–102.
45. Frühbeck, G., Gómez-Ambrosi, J. & Salvador, J. 2001. Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. FASEB J 15, 333–340.
46. Frühbeck, G., Becerril, S., Sainz, N., Garrastachu, P. & García-Velloso, M.J. 2009a. BAT: a new target for human obesity? Trends Pharmacol Sci 30, 387–396.
47. Frühbeck, G., Sesma, P. & Burrell, M.A. 2009b. PRDM16: the interconvertible adipo-myocyte switch. Trends Cell Biol 19, 141–146.
48. Frühbeck, G., Méndez-Giménez, L., Fernández-Formoso, J.A., Fernández, S. & Rodríguez, A. 2014. Regulation of adipocyte lipolysis. Nutr Res Rev 27, 63–93.
49. Fu, T., Seok, S., Choi, S., Huang, Z., Suino-Powell, K., Xu, H.E., Kemper, B. & Kemper, J.K. 2014. MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol Cell Biol 34, 4130–4142.
50. Gallego-Escuredo, J.M., Gómez-Ambrosi, J., Catalán, V., Domingo, P., Giralt, M., Frühbeck, G. & Villarroya, F. 2015. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients. Int J Obes 39, 121–129.
51. Galmozzi, A., Mitro, N., Ferrari, A., Gers, E., Gilardi, F., Godio, C., Cermenati, G., Gualerzi, A., Donetti, E., Rotili, D. et al. 2013. Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes 62, 732–742.
52. Gburcik, V., Cawthorn, W.P., Nedergaard, J., Timmons, J.A. & Cannon, B. 2012. An essential role for Tbx15 in the differentiation of brown and “brite” but not white adipocytes. Am J Physiol Endocrinol Metab 303, E1053–E1060.
53. Ghorbani, M., Claus, T.H. & Himms-Hagen, J. 1997. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist. Biochem Pharmacol 54, 121–131.
54. Giordano, A., Smorlesi, A., Frontini, A., Barbatelli, G. & Cinti, S. 2014. White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ. Eur J Endocrinol 170, R159–R171.
55. Giralt, M., Gavalda-Navarro, A. & Villarroya, F. 2015. Fibroblast growth factor-21, energy balance and obesity. Mol Cell Endocrinol 418, 66–73.
56. Gómez-Ambrosi, J., Rodríguez, A., Catalán, V. & Frühbeck, G. 2008. The bone-adipose axis in obesity and weight loss. Obes Surg 18, 1134–1143.
57. Gouni-Berthold, I., Berthold, H.K., Huh, J.Y., Berman, R., Spenrath, N., Krone, W. & Mantzoros, C.S. 2013. Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo. PLoS ONE 8, e72858.
58. Gustafson, B., Hammarstedt, A., Hedjazifar, S., Hoffmann, J.M., Svensson, P.A., Grimsby, J., Rondinone, C. & Smith, U. 2015. BMP4 and BMP antagonists regulate human white and beige adipogenesis. Diabetes 64, 1670–1681.
59. Gutierrez-Repiso, C., Garcia-Serrano, S., Rodriguez-Pacheco, F., Garcia-Escobar, E., Haro-Mora, J.J., Garcia-Arnes, J., Valdes, S., Gonzalo, M., Soriguer, F., Moreno-Ruiz, F.J., Rodriguez-Cañete, A., Martinez-Ferriz, A., Santoyo, J.S., Perez-Valero, V. & Garcia-Fuentes, E. 2014. FNDC5 could be regulated by leptin in adipose tissue. Eur J Clin Invest 44, 918–925.
60. van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Moller, K., Saltin, B., Febbraio, M.A. & Pedersen, B.K. 2003. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88, 3005–3010.
61. Hamrick, M.W., Herberg, S., Arounleut, P., He, H.Z., Shiver, A., Qi, R.Q., Zhou, L., Isales, C.M. & Mi, Q.S. 2010. The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun 400, 379–383.
62. Handschin, C. & Spiegelman, B.M. 2008. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454, 463–469.
63. Harms, M. & Seale, P. 2013. Brown and beige fat: development, function and therapeutic potential. Nat Med 19, 1252–1263.
64. Harms, M.J., Lim, H.W., Ho, Y., Shapira, S.N., Ishibashi, J., Rajakumari, S., Steger, D.J., Lazar, M.A., Won, K.J. & Seale, P. 2015. PRDM16 binds MED1 and controls chromatin architecture to determine a brown fat transcriptional program. Genes Dev 29, 298–307.
65. Harvey, J. & Ashford, M.L. 2003. Leptin in the CNS: much more than a satiety signal. Neuropharmacology 44, 845–854.
66. Haugen, F., Norheim, F., Lian, H., Wensaas, A.J., Dueland, S., Berg, O., Funderud, A., Skalhegg, B.S., Raastad, T. & Drevon, C.A. 2010. IL-7 is expressed and secreted by human skeletal muscle cells. Am J Physiol Cell Physiol 298, C807–C816.
67. Hecksteden, A., Wegmann, M., Steffen, A., Kraushaar, J., Morsch, A., Ruppenthal, S., Kaestner, L. & Meyer, T. 2013. Irisin and exercise training in humans – results from a randomized controlled training trial. BMC Med 11, 235.
68. Hill, J.J., Davies, M.V., Pearson, A.A., Wang, J.H., Hewick, R.M., Wolfman, N.M. & Qiu, Y. 2002. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 277, 40735–40741.
69. Hoffner, L., Nielsen, J.J., Langberg, H. & Hellsten, Y. 2003. Exercise but not prostanoids enhance levels of vascular endothelial growth factor and other proliferative agents in human skeletal muscle interstitium. J Physiol 550, 217–225.
70. Hofmann, T., Elbelt, U. & Stengel, A. 2014. Irisin as a muscle-derived hormone stimulating thermogenesis–a critical update. Peptides 54, 89–100.
71. Hojman, P., Pedersen, M., Nielsen, A.R., Krogh-Madsen, R., Yfanti, C., Akerstrom, T., Nielsen, S. & Pedersen, B.K. 2009. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 58, 2797–2801.
72. Hondares, E., Iglesias, R., Giralt, A., González, F.J., Giralt, M., Mampel, T. & Villarroya, F. 2011. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J Biol Chem 286, 12983–12990.
73. Horsley, V., Jansen, K.M., Mills, S.T. & Pavlath, G.K. 2003. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113, 483–494.
74. Huh, J.Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M.T., Schneider, B.E. & Mantzoros, C.S. 2012. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61, 1725–1738.
75. Huh, J.Y., Dincer, F., Mesfum, E. & Mantzoros, C.S. 2014. Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int J Obes 38, 1538–1544.
76. Iida, S., Chen, W., Nakadai, T., Ohkuma, Y. & Roeder, R.G. 2015. PRDM16 enhances nuclear receptor-dependent transcription of the brown fat-specific Ucp1 gene through interactions with Mediator subunit MED1. Genes Dev 29, 308–321.
77. Izumiya, Y., Bina, H.A., Ouchi, N., Akasaki, Y., Kharitonenkov, A. & Walsh, K. 2008. FGF21 is an Akt-regulated myokine. FEBS Lett 582, 3805–3810.
78. James, P.L., Jones, S.B., Busby, W.H. Jr, Clemmons, D.R. & Rotwein, P. 1993. A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J Biol Chem 268, 22305–22312.
79. Jedrychowski, M.P., Wrann, C.D., Paulo, J.A., Gerber, K.K., Szpyt, J., Robinson, M.M., Nair, K.S., Gygi, S.P. & Spiegelman, B.M. 2015. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metab 22, 734–740.
80. Jespersen, N.Z., Larsen, T.J., Peijs, L., Daugaard, S., Homoe, P., Loft, A., de Jong, J., Mathur, N., Cannon, B., Nedergaard, J., Pedersen, B.K., Moller, K. & Scheele, C. 2013. A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab 17, 798–805.
81. Jorgensen, L.H., Petersson, S.J., Sellathurai, J., Andersen, D.C., Thayssen, S., Sant, D.J., Jensen, C.H. & Schroder, H.D. 2009. Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle. J Histochem Cytochem 57, 29–39.
82. Joulia, D., Bernardi, H., Garandel, V., Rabenoelina, F., Vernus, B. & Cabello, G. 2003. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 286, 263–275.
83. Jung, T.W., Hwang, H.J., Hong, H.C., Yoo, H.J., Baik, S.H. & Choi, K.M. 2015. BAIBA attenuates insulin resistance and inflammation induced by palmitate or a high fat diet via an AMPK-PPARδ-dependent pathway in mice. Diabetologia 58, 2096–2105.
84. Kammoun, H.L. & Febbraio, M.A. 2014. Come on BAIBA light my fire. Cell Metab 19, 1–2.
85. Kanzleiter, T., Rath, M., Gorgens, S.W., Jensen, J., Tangen, D.S., Kolnes, A.J., Kolnes, K.J., Lee, S., Eckel, J., Schurmann, A. & Eckardt, K. 2014. The myokine decorin is regulated by contraction and involved in muscle hypertrophy. Biochem Biophys Res Commun 450, 1089–1094.
86. Keipert, S., Ost, M., Johann, K., Imber, F., Jastroch, M., van Schothorst, E.M., Keijer, J. & Klaus, S. 2014. Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. Am J Physiol Endocrinol Metab 306, E469–E482.
87. Kelly, D.P. 2012. Medicine. Irisin, light my fire. Science 336, 42–43.
88. Kharitonenkov, A., Shiyanova, T.L., Koester, A., Ford, A.M., Micanovic, R., Galbreath, E.J., Sandusky, G.E., Hammond, L.J., Moyers, J.S., Owens, R.A. et al. 2005. FGF-21 as a novel metabolic regulator. J Clin Invest 115, 1627–1635.
89. Kim, K.H., Kim, S.H., Min, Y.K., Yang, H.M., Lee, J.B. & Lee, M.S. 2013. Acute exercise induces FGF21 expression in mice and in healthy humans. PLoS ONE 8, e63517.
90. Knudsen, J.G., Murholm, M., Carey, A.L., Bienso, R.S., Basse, A.L., Allen, T.L., Hidalgo, J., Kingwell, B.A., Febbraio, M.A., Hansen, J.B. & Pilegaard, H. 2014. Role of IL-6 in exercise training- and cold-induced UCP1 expression in subcutaneous white adipose tissue. PLoS ONE 9, e84910.
91. Kurdiova, T., Balaz, M., Vician, M., Maderova, D., Vlcek, M., Valkovic, L., Srbecky, M., Imrich, R., Kyselovicova, O., Belan, V. et al. 2014. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol 592, 1091–1107.
92. Lebrasseur, N.K. 2012. Building muscle, browning fat and preventing obesity by inhibiting myostatin. Diabetologia 55, 13–17.
93. Lee, S.J. & McPherron, A.C. 2001. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 98, 9306–9311.
94. Lee, Y.H., Petkova, A.P., Mottillo, E.P. & Granneman, J.G. 2012. In vivo identification of bipotential adipocyte progenitors recruited by β3-adrenoceptor activation and high-fat feeding. Cell Metab 15, 480–491.
95. Lee, P., Linderman, J.D., Smith, S., Brychta, R.J., Wang, J., Idelson, C., Perron, R.M., Werner, C.D., Phan, G.Q., Kammula, U.S., Kebebew, E., Pacak, K., Chen, K.Y. & Celi, F.S. 2014. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab 19, 302–309.
96. Li, Z.Y., Zheng, S.L., Wang, P., Xu, T.Y., Guan, Y.F., Zhang, Y.J. & Miao, C.Y. 2014. Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression. CNS Neurosci Ther 20, 344–354.
97. Li, D.J., Huang, F., Lu, W.J., Jiang, G.J., Deng, Y.P. & Shen, F.M. 2015a. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation. Acta Physiol 213, 711–721.
98. Li, Z.Y., Song, J., Zheng, S.L., Fan, M.B., Guan, Y.F., Qu, Y., Xu, J., Wang, P. & Miao, C.Y. 2015b. Adipocyte Metrnl antagonizes insulin resistance through PPARγ ignaling. Diabetes 64, 4011–4022.
99. Lin, J.W., Tsai, C.C., Chen, L.J., Niu, H.S., Chang, C.K. & Niu, C.S. 2014. Characterization of musclin as a new target for treatment of hypertension. Biomed Res Int 2014, 354348.
100. Lin, J.Z., Martagon, A.J., Cimini, S.L., Gonzalez, D.D., Tinkey, D.W., Biter, A., Baxter, J.D., Webb, P., Gustafsson, J.A., Hartig, S.M. & Phillips, K.J. 2015. Pharmacological activation of thyroid hormone receptors elicits a functional conversion of white to brown fat. Cell Rep 13, 1528–1537.
101. Maffei, M., Halaas, J., Ravussin, E., Pratley, R.E., Lee, G.H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S. et al. 1995. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1, 1155–1161.
102. Maisonneuve, C., Igoudjil, A., Begriche, K., Letteron, P., Guimont, M.C., Bastin, J., Laigneau, J.P., Pessayre, D. & Fromenty, B. 2004. Effects of zidovudine, stavudine and beta-aminoisobutyric acid on lipid homeostasis in mice: possible role in human fat wasting. Antivir Ther 9, 801–810.
103. van Marken Lichtenbelt, W.D., Vanhommerig, J.W., Smulders, N.M., Drossaerts, J.M., Kemerink, G.J., Bouvy, N.D., Schrauwen, P. & Teule, G.J. 2009. Cold-activated brown adipose tissue in healthy men. N Engl J Med 360, 1500–1508.
104. McCroskery, S., Thomas, M., Maxwell, L., Sharma, M. & Kambadur, R. 2003. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162, 1135–1147.
105. McPherron, A.C. & Lee, S.J. 2002. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109, 595–601.
106. McPherron, A.C., Lawler, A.M. & Lee, S.J. 1997. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83–90.
107. Miccheli, A., Capuani, G., Marini, F., Tomassini, A., Pratico, G., Ceccarelli, S., Gnani, D., Baviera, G., Alisi, A., Putignani, L. & Nobili, V. 2015. Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. Int J Obes 39, 1118–1125.
108. Moreno-Navarrete, J.M., Ortega, F., Serrano, M., Guerra, E., Pardo, G., Tinahones, F., Ricart, W. & Fernández-Real, J.M. 2013. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 98, E769–E778.
109. Mori, M., Nakagami, H., Rodriguez-Araujo, G., Nimura, K. & Kaneda, Y. 2012. Essential role for miR-196a in brown adipogenesis of white fat progenitor cells. PLoS Biol 10, e1001314.
110. Mortensen, O.H., Andersen, K., Fischer, C., Nielsen, A.R., Nielsen, S., Akerstrom, T., Aastrom, M.B., Borup, R. & Pedersen, B.K. 2008. Calprotectin is released from human skeletal muscle tissue during exercise. J Physiol 586, 3551–3562.
111. Mouisel, E., Relizani, K., Mille-Hamard, L., Denis, R., Hourde, C., Agbulut, O., Patel, K., Arandel, L., Morales-Gonzalez, S., Vignaud, A. et al. 2014. Myostatin is a key mediator between energy metabolism and endurance capacity of skeletal muscle. Am J Physiol Regul Integr Comp Physiol 307, R444–R454.
112. Mousavi, K. & Jasmin, B.J. 2006. BDNF is expressed in skeletal muscle satellite cells and inhibits myogenic differentiation. J Neurosci 26, 5739–5749.
113. Muise, E.S., Azzolina, B., Kuo, D.W., El-Sherbeini, M., Tan, Y., Yuan, X., Mu, J., Thompson, J.R., Berger, J.P. & Wong, K.K. 2008. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol Pharmacol 74, 403–412.
114. Muoio, D.M., Dohm, G.L., Fiedorek, F.T. Jr, Tapscott, E.B. & Coleman, R.A. 1997. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46, 1360–1363.
115. Murano, I., Barbatelli, G., Giordano, A. & Cinti, S. 2009. Noradrenergic parenchymal nerve fiber branching after cold acclimatisation correlates with brown adipocyte density in mouse adipose organ. J Anat 214, 171–178.
116. Nedergaard, J. & Cannon, B. 2014. The browning of white adipose tissue: some burning issues. Cell Metab 20, 396–407.
117. Nedergaard, J., Bengtsson, T. & Cannon, B. 2007. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293, E444–E452.
118. Neufer, P.D., Bamman, M.M., Muoio, D.M., Bouchard, C., Cooper, D.M., Goodpaster, B.H., Booth, F.W., Kohrt, W.M, Gerszten, R.E., Mattson, M.P. et al. 2015. Understanding the cellular and molecular mechanisms of physical activity-induced health benefits. Cell Metab 22, 4–11.
119. Nguyen, K.D., Qiu, Y., Cui, X., Goh, Y.P., Mwangi, J., David, T., Mukundan, L., Brombacher, F., Locksley, R.M. & Chawla, A. 2011a. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480, 104–108.
120. Nguyen, M.H., Cheng, M. & Koh, T.J. 2011b. Impaired muscle regeneration in ob/ob and db/db mice. ScientificWorldJournal 11, 1525–1535.
121. Nishimura, T., Nakatake, Y., Konishi, M. & Itoh, N. 2000. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492, 203–206.
122. Nishizawa, H., Matsuda, M., Yamada, Y., Kawai, K., Suzuki, E., Makishima, M., Kitamura, T. & Shimomura, I. 2004. Musclin, a novel skeletal muscle-derived secretory factor. J Biol Chem 279, 19391–19395.
123. Norheim, F., Raastad, T., Thiede, B., Rustan, A.C., Drevon, C.A. & Haugen, F. 2011. Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am J Physiol Endocrinol Metab 301, E1013–E1021.
124. Norheim, F., Langleite, T.M., Hjorth, M., Holen, T., Kielland, A., Stadheim, H.K., Gulseth, H.L., Birkeland, K.I., Jensen, J. & Drevon, C.A. 2014. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J 281, 739–749.
125. Ouchi, N., Oshima, Y., Ohashi, K., Higuchi, A., Ikegami, C., Izumiya, Y. & Walsh, K. 2008. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J Biol Chem 283, 32802–32811.
126. Pedersen, B.K. 2009. Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol (1985), 107, 1006–1014.
127. Pedersen, B.K. & Febbraio, M.A. 2008. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88, 1379–1406.
128. Pedersen, B.K. & Febbraio, M.A. 2012. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8, 457–465.
129. Petrovic, N., Walden, T.B., Shabalina, I.G., Timmons, J.A., Cannon, B. & Nedergaard, J. 2010. Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem 285, 7153–7164.
130. Pownall, M.E., Gustafsson, M.K. & Emerson, C.P. Jr 2002. Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu Rev Cell Dev Biol 18, 747–783.
131. Qian, S.W., Tang, Y., Li, X., Liu, Y., Zhang, Y.Y., Huang, H.Y., Xue, R.D., Yu, H.Y., Guo, L., Gao, H.D., Sun, X., Li, Y.M., Jia, W.P. & Tang, Q.Q. 2013. BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proc Natl Acad Sci USA 110, E798–E807.
132. Qiang, L., Wang, L., Kon, N., Zhao, W., Lee, S., Zhang, Y., Rosenbaum, M., Zhao, Y., Gu, W., Farmer, S.R. & Accili, D. 2012. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell 150, 620–632.
133. Quiñones, M., Folgueira, C., Sánchez-Rebordelo, E. & Al-Massadi, O. 2015. Circulating irisin levels are not regulated by nutritional status, obesity, or leptin levels in rodents. Mediators Inflamm 2015, 620919.
134. Rao, R.R., Long, J.Z., White, J.P., Svensson, K.J., Lou, J., Lokurkar, I., Jedrychowski, M.P., Ruas, J.L., Wrann, C.D., Lo, J.C. et al. 2014. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 157, 1279–1291.
135. Raschke, S. & Eckel, J. 2013. Adipo-myokines: two sides of the same coin–mediators of inflammation and mediators of exercise. Mediators Inflamm 2013, 320724.
136. Raschke, S., Eckardt, K., Bjorklund Holven, K., Jensen, J. & Eckel, J. 2013a. Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells. PLoS ONE 8, e62008.
137. Raschke, S., Elsen, M., Gassenhuber, H., Sommerfeld, M., Schwahn, U., Brockmann, B., Jung, R., Wisloff, U., Tjonna, A.E., Raastad, T. et al. 2013b. Evidence against a beneficial effect of irisin in humans. PLoS ONE 8, e73680.
138. Relizani, K., Mouisel, E., Giannesini, B., Hourdé, C., Patel, K., Morales Gonzalez, S., Julich, K., Vignaud, A., Pietri-Rouxel, F., Fortin, D. et al. 2014. Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy. Mol Ther 22, 1423–1433.
139. Roberts, M.D., Bayless, D.S., Company, J.M., Jenkins, N.T., Padilla, J., Childs, T.E., Martin, J.S., Dalbo, V.J., Booth, F.W., Rector, R.S. & Laughlin, M.H. 2013. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats. Metabolism 62, 1052–1056.
140. Roberts, L.D., Bostrom, P., O'Sullivan, J.F., Schinzel, R.T., Lewis, G.D., Dejam, A., Lee, Y.K., Palma, M.J., Calhoun, S., Georgiadi, A. et al. 2014. β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab 19, 96–108.
141. Roca-Rivada, A., Castelao, C., Senin, L.L., Landrove, M.O., Baltar, J., Crujeiras, A.B., Seoane, L.M., Casanueva, F.F. & Pardo, M. 2013. FNDC5/irisin is not only a myokine but also an adipokine. PLoS ONE 8, e60563.
142. Rodríguez, A., Becerril, S., Méndez-Giménez, L., Ramírez, B., Sáinz, N., Catalán, V., Gómez-Ambrosi, J. & Frühbeck, G. 2015a. Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms, but reduces its effect on subcutaneous fat browning in mice. Int J Obes 39, 397–407.
143. Rodríguez, A., Ezquerro, S., Méndez-Giménez, L., Becerril, S. & Frühbeck, G. 2015b. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am J Physiol Endocrinol Metab 309, E691–E714.
144. Rosen, E.D., Walkey, C.J., Puigserver, P. & Spiegelman, B.M. 2000. Transcriptional regulation of adipogenesis. Genes Dev 14, 1293–1307.
145. Ruas, J.L., White, J.P., Rao, R.R., Kleiner, S., Brannan, K.T., Harrison, B.C., Greene, N.P., Wu, J., Estall, J.L., Irving, B.A. et al. 2012. A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell 151, 1319–1331.
146. Sáinz, N., Rodríguez, A., Catalán, V., Becerril, S., Ramírez, B., Gómez-Ambrosi, J. & Frühbeck, G. 2009. Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1alpha in ob/ob mice. PLoS ONE 4, e6808.
147. Sáinz, N., Rodríguez, A., Catalán, V., Becerril, S., Ramírez, B., Gómez-Ambrosi, J. & Frühbeck, G. 2010. Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob/ob mice. Mediators Inflamm 2010, 784343.
148. Sáinz, N., Rodríguez, A., Catalán, V., Becerril, S., Ramírez, B., Lancha, A., Burgos-Ramos, E., Gómez-Ambrosi, J. & Frühbeck, G. 2012. Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob/ob mice. PLoS ONE 7, e29389.
149. Saito, M., Okamatsu-Ogura, Y., Matsushita, M., Watanabe, K., Yoneshiro, T., Nio-Kobayashi, J., Iwanaga, T., Miyagawa, M., Kameya, T., Nakada, K., Kawai, Y. & Tsujisaki, M. 2009. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58, 1526–1531.
150. Scarpace, P.J., Matheny, M., Pollock, B.H. & Tumer, N. 1997. Leptin increases uncoupling protein expression and energy expenditure. Am J Physiol 273, E226–E230.
151. Schuelke, M., Wagner, K.R., Stolz, L.E., Hubner, C., Riebel, T., Komen, W., Braun, T., Tobin, J.F. & Lee, S.J. 2004. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350, 2682–2688.
152. Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L.M., Uldry, M., Tavernier, G., Langin, D. & Spiegelman, B.M. 2007. Transcriptional control of brown fat determination by PRDM16. Cell Metab 6, 38–54.
153. Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scime, A., Devarakonda, S., Conroe, H.M., Erdjument-Bromage, H., Tempst, P., Rudnicki, M.A., Beier, D.R. & Spiegelman, B.M. 2008. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454, 961–967.
154. Seale, P., Kajimura, S. & Spiegelman, B.M. 2009. Transcriptional control of brown adipocyte development and physiological function–of mice and men. Genes Dev 23, 788–797.
155. Seldin, M.M., Peterson, J.M., Byerly, M.S., Wei, Z. & Wong, G.W. 2012. Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem 287, 11968–11980.
156. Shan, T., Liang, X., Bi, P. & Kuang, S. 2013. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle. FASEB J 27, 1981–1989.
157. Sharp, L.Z., Shinoda, K., Ohno, H., Scheel, D.W., Tomoda, E., Ruiz, L., Hu, H., Wang, L., Pavlova, Z., Gilsanz, V. & Kajimura, S. 2012. Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS ONE 7, e49452.
158. Singh, R., Bhasin, S., Braga, M., Artaza, J.N., Pervin, S., Taylor, W.E., Krishnan, V., Sinha, S.K., Rajavashisth, T.B. & Jasuja, R. 2009. Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/beta-catenin and follistatin/transforming growth factor-beta signaling pathways. Endocrinology 150, 1259–1268.
159. Smith, S.B., Carstens, G.E., Randel, R.D., Mersmann, H.J. & Lunt, D.K. 2004. Brown adipose tissue development and metabolism in ruminants. J Anim Sci 82, 942–954.
160. Stanford, K.I., Middelbeek, R.J. & Goodyear, L.J. 2015a. Exercise effects on white adipose tissue: beiging and metabolic adaptations. Diabetes 64, 2361–2368.
161. Stanford, K.I., Middelbeek, R.J., Townsend, K.L., Lee, M.Y., Takahashi, H., So, K., Hitchcox, K.M., Markan, K.R., Hellbach, K., Hirshman, M.F., Tseng, Y.H. & Goodyear, L.J. 2015b. A novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis. Diabetes 64, 2002–2014.
162. Steele, F.R., Chader, G.J., Johnson, L.V. & Tombran-Tink, J. 1993. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA 90, 1526–1530.
163. Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B. & Klarlund Pedersen, B. 2000. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529(Pt 1), 237–242.
164. Stefan, N. & Häring, H.U. 2013. The role of hepatokines in metabolism. Nat Rev Endocrinol 9, 144–152.
165. Swick, A.G., Orena, S. & O'Connor, A. 2013. Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism 62, 1070–1073.
166. Taga, H., Chilliard, Y., Meunier, B., Chambon, C., Picard, B., Zingaretti, M.C., Cinti, S. & Bonnet, M. 2012. Cellular and molecular large-scale features of fetal adipose tissue: is bovine perirenal adipose tissue brown? J Cell Physiol 227, 1688–1700.
167. Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G.J., Campfield, L.A., Clark, F.T., Deeds, J. et al. 1995. Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263–1271.
168. Thomas, M., Langley, B., Berry, C., Sharma, M., Kirk, S., Bass, J. & Kambadur, R. 2000. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275, 40235–40243.
169. Tiano, J.P., Springer, D.A. & Rane, S.G. 2015. SMAD3 negatively regulates serum irisin and skeletal muscle FNDC5 and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) during exercise. J Biol Chem 290, 11431.
170. Timmons, J.A., Baar, K., Davidsen, P.K. & Atherton, P.J. 2012. Is irisin a human exercise gene? Nature 488, E9–E10; discussion E10-11.
171. Trajkovski, M., Ahmed, K., Esau, C.C. & Stoffel, M. 2012. MyomiR-133 regulates brown fat differentiation through Prdm16. Nat Cell Biol 14, 1330–1335.
172. Tseng, Y.H., Kokkotou, E., Schulz, T.J., Huang, T.L., Winnay, J.N., Taniguchi, C.M., Tran, T.T., Suzuki, R., Espinoza, D.O., Yamamoto, Y., Ahrens, M.J., Dudley, A.T., Norris, A.W., Kulkarni, R.N. & Kahn, C.R. 2008. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454, 1000–1004.
173. Ushach, I., Burkhardt, A.M., Martinez, C., Hevezi, P.A., Gerber, P.A., Buhren, B.A., Schrumpf, H., Valle-Rios, R., Vazquez, M.I., Homey, B. & Zlotnik, A. 2015. METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages. Clin Immunol 156, 119–127.
174. Vamvini, M.T., Aronis, K.N., Panagiotou, G., Huh, J.Y., Chamberland, J.P., Brinkoetter, M.T., Petrou, M., Christophi, C.A., Kales, S.N., Christiani, D.C. & Mantzoros, C.S. 2013. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. Eur J Endocrinol 169, 829–834.
175. Vaughan, R.A., Gannon, N.P., Barberena, M.A., Garcia-Smith, R., Bisoffi, M., Mermier, C.M., Conn, C.A. & Trujillo, K.A. 2014. Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes Metab 16, 711–718.
176. Vijgen, G.H., Bouvy, N.D., Teule, G.J., Brans, B., Schrauwen, P. & van Marken Lichtenbelt, W.D. 2010. Brown adipose tissue in morbidly obese subjects. PLoS ONE 6, e17247.
177. Villarroya, F. & Vidal-Puig, A. 2013. Beyond the sympathetic tone: the new brown fat activators. Cell Metab 17, 638–643.
178. Virtanen, K.A., Lidell, M.E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.J., Enerback, S. & Nuutila, P. 2009. Functional brown adipose tissue in healthy adults. N Engl J Med 360, 1518–1525.
179. Vosselman, M.J., Hoeks, J., Brans, B., Pallubinsky, H., Nascimento, E.B., van der Lans, A.A., Broeders, E.P., Mottaghy, F.M., Schrauwen, P. & van Marken Lichtenbelt, W.D. 2015. Low brown adipose tissue activity in endurance-trained compared with lean sedentary men. Int J Obes 39, 1696–1702.
180. Walden, T.B., Hansen, I.R., Timmons, J.A., Cannon, B. & Nedergaard, J. 2011. Recruited vs. nonrecruited molecular signatures of brown, “brite”, and white adipose tissues. Am J Physiol Endocrinol Metab 302, E19–E31.
181. Wang, L., Teng, R., Di, L., Rogers, H., Wu, H., Kopp, J.B. & Noguchi, C.T. 2013. PPARalpha and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes 62, 4122–4131.
182. Wang, W., Kissig, M., Rajakumari, S., Huang, L., Lim, H.W., Won, K.J. & Seale, P. 2014. Ebf2 is a selective marker of brown and beige adipogenic precursor cells. Proc Natl Acad Sci USA 111, 14466–14471.
183. Wente, W., Efanov, A.M., Brenner, M., Kharitonenkov, A., Koster, A., Sandusky, G.E., Sewing, S., Treinies, I., Zitzer, H. & Gromada, J. 2006. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. Diabetes 55, 2470–2478.
184. Whittle, A.J., Carobbio, S., Martins, L., Slawik, M., Hondares, E., Vázquez, M.J., Morgan, D., Csikasz, R.I., Gallego, R., Rodríguez-Cuenca, S. et al. 2012. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 149, 871–885.
185. Wrann, C.D., White, J.P., Salogiannnis, J., Laznik-Bogoslavski, D., Wu, J., Ma, D., Lin, J.D., Greenberg, M.E. & Spiegelman, B.M. 2013. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab 18, 649–659.
186. Wu, J., Böstrom, P., Sparks, L.M., Ye, L., Choi, J.H., Giang, A.H., Khandekar, M., Virtanen, K.A., Nuutila, P., Schaart, G. et al. 2012. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366–376.
187. Yang, M., Wei, D., Mo, C., Zhang, J., Wang, X., Han, X., Wang, Z. & Xiao, H. 2013. Saturated fatty acid palmitate-induced insulin resistance is accompanied with myotube loss and the impaired expression of health benefit myokine genes in C2C12 myotubes. Lipids Health Dis 12, 104.
188. Zeng, L., Akasaki, Y., Sato, K., Ouchi, N., Izumiya, Y. & Walsh, K. 2010. Insulin-like 6 is induced by muscle injury and functions as a regenerative factor. J Biol Chem 285, 36060–36069.
189. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. & Friedman, J.M. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432.
190. Zhang, C., McFarlane, C., Lokireddy, S., Masuda, S., Ge, X., Gluckman, P.D., Sharma, M. & Kambadur, R. 2012. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 55, 183–193.
191. Zhang, Y., Li, R., Meng, Y., Li, S., Donelan, W., Zhao, Y., Qi, L., Zhang, M., Wang, X., Cui, T., Yang, L.J. & Tang, D. 2014. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 63, 514–525.
192. Zimmers, T.A., Davies, M.V., Koniaris, L.G., Haynes, P., Esquela, A.F., Tomkinson, K.N., McPherron, A.C., Wolfman, N.M. & Lee, S.J. 2002. Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486–1488.